1.Regulating mechanism of chemokine of CXCL12 on the progress of gastric cancer
International Journal of Surgery 2015;42(7):501-504
The chemokine CXCL12 and its receptor CXCR4 played a very important role in the gastric carcinoma,which promoted the growth,invasion,and metastasis of the gastric carcinoma through various of signal pathways.In this paper,the literatures related CXCL12,signal pathways and gastric carcinoma were retrieved and explored.And the authors present the research progress concerning the roles of CXCL12 and its regulating mechanism in neoplasm,especially in gastric cancer.
2.ADVANCES AND CURRENT STATUS IN THE STUDY ON QUALITY OF LIFE AFTER OPERATION OF RECTAL CANCER
Chinese Journal of Bases and Clinics in General Surgery 2001;8(1):62-64
Objective To summarize the advances in the clinical application of the quality of life(QOL) assessment after surgery of rectal cancer. Methods The recent literatures on the advances in the studies on the QOL assessment following the treatment of rectal cancer were reviewed. Results After surgery of rectal cancer, the patients might suffer from short and/or long term of various complications affecting the physical, social and psychological aspects of their well-being. The QOL assessment included many aspects of the studies. Global QOL scores as measured by the specific questionnaires improved significantly after surgery. It had provided clinical evidences of therapeutic methods, operative treatment of choices and bowel reconstructed procedures for the patients with rectal cancer.Conclusion The QOL studies after surgery for rectal cancer are of increasing importance. Apart from the improvements of the survival rates and the recurrence-free period, it is essential to provide an acceptable QOL postoperatively. The QOL assessment for the guidance of clinical treatment should be discussed routinely for a patient with potentially curable rectal carcinoma so that the excellent outcome could be achieved.
3.Progress of stem cell surface marker CD133 in gastric cancer
Shoulian WANG ; Ruiqi LU ; Bojian JIANG
International Journal of Surgery 2012;39(1):56-59
The morbidity and mortality of gastric cancer stand in the first place among all kinds of malignant tumours in our country,the early diagnosis rate is still very low and the prognosis is unsatisfactory also.The expression of CD133 probably as a tumour stem cell marker is significantly higher in gastric cancer primary lesion than that in normal tissue and its higher expression corelates with the larger size of tumor,lymph node metastasis occurences and poorer prognosis.Meanwhile,the positive expression of CD133 may have some relationship with the angiogenesis,severer infiltration depth,worse differentiation degree and later TNM stage of gastric cancer.This paper aims at further recongnizing the specific expression of CD133 in gastric cancer primary lesion,both the relationship with initiating and clinical pathological features of gastric cancer,so as to bring a new research direction for early diagnosis and targeted therapy of stomach cancer.
4.Research progress of gallbladder carcinoma and neoplastic stem cells
Yuanlin YU ; Bojian JIANG ; Jiwei YU
International Journal of Surgery 2012;39(9):615-618
Gallbladder carcinoma is the most common malignant tumor in biliary system,the early diagnosis rate is still very low and the prognosis is extremely poor.At present,the pathogenesis of gallbladder is not clear.Recently,with the development of the neoplastic stem cell research on gallbladder carcinoma,the latest study showed SP positive cells could be separated from the GBC-SD cell.Further more,related researches have shown that gallbladder respectively with CD133+ cells,CD44+ cells,CD133+ CD44+ cells had possessed the cloned formation ability,the stronger growth ability,the differentiation capacity and forming-tumor ability.In this review,we will discuss the research of the relationship between the gallbladder carcinoma and neoplastic stem cells.
5.Role of long non-coding RNA in the gastric cancer
Xiaolong XI ; Bojian JIANG ; Jiwei YU
International Journal of Surgery 2014;41(7):484-486
Long non-coding RNA (LncRNA) is a kind of length greater than 200 nucleotides not encode any proteins RNA molecules.Although not encode any proteins,LncRNA through chromatin modification,transcription activation and interference et al.involved in a variety of control process in the cell.In recent years,the study found that the expression of a variety of LncRNA abnormalities in gastric cancer.These changes are closely associated with the development and prognosis of gastric cancer,regulate the expression of related LncRNA can significantly improve the prognosis of patients.Targeted to regulate the expression of LncRNA can provide new strategies for treatment of gastric cancer.
6.Application status of laparoscopic gastrectomy in the treatment of gastric cancer
Shuzheng SONG ; Jiwei YU ; Bojian JIANG
International Journal of Surgery 2014;41(7):476-480
Nowadays,laparoscopy has already been widely applied to the diagnosis and treatment of kinds of diseases,improving the outcome of the patients with its less invasive advantages.In the treatment of gastric cancer,doctors always choose different methods of laparoscopic gastrectomy(LG) according to the tumor's location and its invasion and metastasis.But LG hasn't got widely application in the treatment of gastric cancer,which is meanly attributed to the exist of some Technical problems,failing to control the complications very well and the lack of evidence of long-term oncological outcomes.But with the development of new technology and the accumulation of the surgeons' experience,these problems might be conquered to a certain extent.In this review,the author will summary the application status of LG in the treatment of gastric cancer.
7.Resistance to chemotherapy and targeting therapy regarding to microenvironment of cancer stem cells
Jia WANG ; Jiwei YU ; Bojian JIANG
International Journal of Surgery 2013;(6):408-412
Cancer stem cells are special stem cells and are found recently in many tumors,and have the capability of self renewal and differentiation and can gradually differentiate into matured tumor cells to form the primary lesion and the various metastasis lesions of tumors.As well known,cancer stem cells shared strong ability of resistant to chemotherapy and/or radiotherapy,which is mainly related to many kinds of molecules and theirs relative regulation in niche regarding to cancer stem cells.Currently,the strategies of some novel therapies are conducted to detect the targeting sites with relevant to the microenvironments of cancer stem cells,such as the angiogenesis and epithelial-mesenchymal transition of cancer stem cells.Furthermore,insights into drug-resistance of cancer stem cells and its niche may offer new therapeutic strategies for the treatment of tumors.
8.Researching Progress of The Relationship of VEGF-C and Its Receptor with Lymphatic Metastasis In Gastric Cancer
Shenghua WU ; Jiwei YU ; Bojian JIANG
Chinese Journal of Bases and Clinics in General Surgery 2008;0(08):-
Objective To investigate the role of vascular endothelial growth factor-C (VEGF-C) and its receptors in the formation of lymphatic vessels and lymphatic metastasis in gastric cancer. Methods By the domestic and overseas literatures review,the expressions of VEGF-C and its receptors in gastric cancer,their role in tumor lymphatic metastasis and prospect in treatment of gastric cancer were summarized. Results There was a significant correlation between VEGF-C and its receptors and the formation of lymphatic vessels and lymphatic metastasis in gastric cancer. VEGF-C high expression might be an early event in lymphatic metastasis and could be considered as an independent predictive factor of lymphaticmicrometastasis. By inhibition of gastric cancer cell from secrete VEGF-C or blockage of the interaction of VEGF-C with VEGFR-3,it was possible to inhibit tumor angiogenesis and the invasion and distant spread of cancer cells,thereby decreased mortality and improve survival. Conclusion VEGF-C and its receptors may promote the formation of lymphatic vessels and lymphatic metastasis in gastric cancer. It may be an effective way to gastric cancer for the treatments against VEGF-C and its receptors.
9.Carcinoid tumors of the appendix:a report of 21 cases
Hong CHEN ; Bojian JIANG ; Changling TU
Chinese Journal of General Surgery 2001;0(09):-
Objective To summarize the diagnosis and treatment experience for patients with appendiceal carcinoid tumors.Methods 21 patients with appendix carcinoid tumors were admitted and received surgery from 1967 to 1997 in our hospital.Results 12 patients (57%) presented with signs and symptoms suggestive of acute appendicitis.In 9 patients(43%) tumors were discovered incidentally.The tumors were at the tip in 17 patients,at the middle third in 3,and at the base of the appendix in one.The tumor was less than 1 cm in diameter in 16 patients,between 1 and 2 cm in 3 patients,and larger than 2 cm in 2 patients.Tumor invasion was confined to the submucosa or muscle layers in 15 patients,serosa involved in 4 patients,and into the meso appendicular fat in the remaining 2 patients.Twenty patients underwent appendectomy alone.One patient with a tumor size larger than 2 cm and positive lymph nodes in the mesoappendix underwent secondary right hemicolectomy.Complete follow up was achieved in 19 patients,and all patients remained free of tumor recurrence and metastasis.Conclusion Appendiceal carcinoids of less than 1 cm could be adequately managed by appendectomy alone.The appropriate treatment for tumors of 1 to 2 cm are still controversial.Right hemicolectomy is recommended for tumors larger than 2 cm .
10.ERCP and EST before laparoscopic cholecystectomy for treatment of patients with cholelithiasts concurrent with choledocholithiasis
Yuanchao ZHENG ; Yan XIA ; Mingzhe HUANG ; Bojian JIANG
International Journal of Surgery 2009;36(9):591-594
Objective To summarize the curative effect of ERCP and EST before laparoseopic cholecystec-tomy for treatment of patients with cbolelithiasts concurrent with choledoeholithiasis. Methods A retrospec-tive analysis was carried out for 43 cases of cholelithiasis concurrent with choledocholithiasis from January 2006 to December 2008. Results The procedures were successfully accomplished in 40 patients, the suc-cess rate was 93%. The successful clearance rate of common bile duct stone was 95.2%. Complication oc-curred in 2 cases, including 1 case of papilla bleeding and 1 case of hyperamylesemia. All complications were cured with non-operating treatment. Conclusions ERCP and EST before laparoseopic cholecystectomy is the best treatment and diagnosis method in gallbladder stone with common bile dust stone. It is very impor-tant to improve the success rate of LC, decrease complication and occurrence of the open operation of com-mon bile duct stone.